Dose-Response Effect of Antibodies to S100 Protein and Cannabinoid Receptor Type 1 in Released-Active Form in the Light-Dark Test in Mice

• Main Authors: Elena V. Kardash (Author), Irina A. Ertuzun (Author), Gul'nara R. Khakimova (Author), Andrey N. Kolyadin (Author), Sergey A. Tarasov (Author), Stéphanie Wagner (Author), Emile Andriambeloson (Author), Vladimir T. Ivashkin (Author), Oleg I. Epstein (Author)
• Format: Book
• Published: SAGE Publishing, 2018-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Earlier studies have shown that combination of antibodies to S100 protein and to cannabinoid receptor type 1 in released-active form (Brizantin) may possess anxiolytic properties and decrease nicotine dependence. Released-active form of antibodies is a novel approach that permits to modify natural f...